Wdnering,

Great job,thanks a lot.Do you know if they are going for HbA1c superiority in just the Type 2 Trial and still aiming for just non-inferiority in the Type 1 Trial?(The Type 1 trial being the one necessary for approval.)

Also this answer certainly instills confidence,doesn't it?

7. Do you stillintend to partner Afrezza?If so, why has a big pharma not concluded a partnership with MannKind by now?A: Yes we are still pursuing partnership opportunities with Afrezza.I don’t understand why we are not getting more traction on the partnership matter.